Journal of Orthopaedic Research 2015-01-01

Parathyroid hormone 1-34 enhances extracellular matrix deposition and organization during flexor tendon repair.

Daniel J Lee, Richard D Southgate, Youssef M Farhat, Alayna E Loiselle, Warren C Hammert, Hani A Awad, Regis J O'Keefe

Index: J. Orthop. Res. 33(1) , 17-24, (2014)

Full Text: HTML

Abstract

Parathyroid hormone (PTH) 1-34 is known to enhance fracture healing. Tendon repair is analogous to bone healing in its dependence on the proliferation and differentiation of mesenchymal stem cells, matrix formation, and tissue remodeling.(1,2,3) We hypothesized that PTH 1-34 enhances tendon healing in a flexor digitorum longus (FDL) tendon repair model. C57Bl/6J mice were treated with either intraperitoneal PTH 1-34 or vehicle-control (PBS). Tendons were harvested at 3-28 days for histology, gene expression, and biomechanical testing. The metatarsophalangeal joint range of motion was reduced 1.5-2-fold in PTH 1-34 mice compared to control mice. The gliding coefficient, a measure of adhesion formation, was 2-3.5-fold higher in PTH 1-34 mice. At 14 days post-repair, the tensile strength was twofold higher in PTH 1-34 specimens, but at 28 days there were no differences. PTH 1-34 mice had increased fibrous tissue deposition that correlated with elevated expression of collagens and fibronectin as seen on quantitative PCR. PTH 1-34 accelerated the deposition of reparative tissue but increased adhesion formation.© 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.


Related Compounds

Related Articles:

G-protein-coupled estrogen receptor 1 is anatomically positioned to modulate synaptic plasticity in the mouse hippocampus.

2015-02-11

[J. Neurosci. 35(6) , 2384-97, (2015)]

Neuroprotective effect of modified Chungsimyeolda-tang, a traditional Korean herbal formula, via autophagy induction in models of Parkinson's disease.

2015-01-15

[J. Ethnopharmacol. 159 , 93-101, (2014)]

Nerve demyelination increases metabotropic glutamate receptor subtype 5 expression in peripheral painful mononeuropathy.

2015-01-01

[Int. J. Mol. Sci. 16(3) , 4642-65, (2015)]

Control of cytoplasmic dynein force production and processivity by its C-terminal domain.

2015-01-01

[Nat. Commun. 6 , 6206, (2015)]

Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.

2013-03-01

[Brain Behav. 3(2) , 75-88, (2013)]

More Articles...